- Home
- SGMO vs OPP Comparison
SGMO vs OPP Comparison
Compare SGMO & OPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- OPP
- Stock Information
- Founded
- SGMO 1995
- OPP 2010
- Country
- SGMO United States
- OPP United States
- Employees
- SGMO N/A
- OPP N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- OPP Finance/Investors Services
- Sector
- SGMO Health Care
- OPP Finance
- Exchange
- SGMO Nasdaq
- OPP Nasdaq
- Market Cap
- SGMO 180.5M
- OPP 200.8M
- IPO Year
- SGMO 2000
- OPP N/A
- Fundamental
- Price
- SGMO $1.96
- OPP $8.44
- Analyst Decision
- SGMO Buy
- OPP
- Analyst Count
- SGMO 3
- OPP 0
- Target Price
- SGMO $7.00
- OPP N/A
- AVG Volume (30 Days)
- SGMO 11.1M
- OPP 108.0K
- Earning Date
- SGMO 11-12-2024
- OPP 01-01-0001
- Dividend Yield
- SGMO N/A
- OPP 14.41%
- EPS Growth
- SGMO N/A
- OPP N/A
- EPS
- SGMO N/A
- OPP N/A
- Revenue
- SGMO $52,291,000.00
- OPP N/A
- Revenue This Year
- SGMO N/A
- OPP N/A
- Revenue Next Year
- SGMO $71.79
- OPP N/A
- P/E Ratio
- SGMO N/A
- OPP N/A
- Revenue Growth
- SGMO N/A
- OPP N/A
- 52 Week Low
- SGMO $0.30
- OPP $7.26
- 52 Week High
- SGMO $3.18
- OPP $8.83
- Technical
- Relative Strength Index (RSI)
- SGMO 51.89
- OPP 32.77
- Support Level
- SGMO $1.82
- OPP $8.34
- Resistance Level
- SGMO $2.11
- OPP $8.79
- Average True Range (ATR)
- SGMO 0.38
- OPP 0.09
- MACD
- SGMO -0.10
- OPP -0.01
- Stochastic Oscillator
- SGMO 16.44
- OPP 22.22
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About OPP RiverNorth/DoubleLine Strategic Opportunity Fund Inc.
RiverNorth/DoubleLine Strategic Opportunity Fund Inc is a closed-end management investment company. The company's investment objective is to seek current income and overall total return.